Where Does a Midline Catheter End in the Body?

A midline catheter tip sits in the large veins of the upper arm, ending just below the axilla — the armpit area. The device is typically 8 to 12 cm long and is threaded from an insertion point on the upper arm into the basilic, brachial, or cephalic vein until its tip reaches the axillary vein region, well short of the heart and the central vasculature. That final resting spot, and its distance from the chest, shapes nearly everything about what a midline can and cannot do.

The Exact Tip Location and Why It Varies

If you picture the veins of the arm as a highway system, a midline catheter travels from a mid-upper-arm on-ramp and merges into progressively larger veins heading toward the shoulder. The catheter tip is generally placed just below the axilla, in the upper portion of the arm’s deep venous system.¹ In practice, the precise landing spot varies from patient to patient. Studies report tip positions ranging from the brachial vein and basilic vein on the lower end to the distal or proximal axillary vein, the axillo-subclavian junction, and occasionally the subclavian vein on the upper end.²

This variability is partly intentional and partly anatomical. People’s arm lengths differ, vein caliber differs, and clinicians may advance or pull back the catheter slightly based on ultrasound imaging during placement. The key boundary to understand is that a midline must remain in the peripheral venous system. Once a catheter tip crosses into the subclavian vein and approaches the superior vena cava, it is functionally acting as a central line and falls under a different set of clinical rules. A midline, by definition, stops short of that territory.

Why a Few Centimeters of Tip Position Matter

You might think that as long as the catheter stays in the arm, the exact spot doesn’t make much difference. Research says otherwise. A study of elderly patients divided midline placements into two groups based on how far the tip sat from the clavicle. Patients whose tips landed in the deeper, more proximal segment of the axillary vein had fewer complications and kept their catheters in place longer than those with tips parked further down the arm.³

A 2025 systematic review and network meta-analysis went further, comparing multiple tip positions head to head. When the tip sat in the subclavian vein rather than the distal axillary vein, the risk of catheter-related thrombosis dropped substantially, occlusion risk fell even more sharply, and phlebitis was also reduced.² The logic is straightforward: larger veins have faster blood flow, which helps dilute the infusate and reduce the mechanical irritation the catheter causes against the vessel wall. A tip sitting in a smaller, slower-flow vein is more likely to trigger clotting or inflammation.

This creates a clinical tension. Pushing the tip too far toward the chest blurs the line between a midline and a central catheter. But leaving it too far down the arm increases the chance of problems. Clinicians increasingly aim for that sweet spot in the proximal axillary vein region, using ultrasound and sometimes chest X-ray or tip-tracking technology to confirm placement.

How a Midline Differs from a PICC

The question “where does it end?” is really a question about what category of device you’re dealing with, and the practical differences between a midline and a peripherally inserted central catheter (PICC) are significant. Both are inserted through veins in the upper arm, often using the same technique and even the same insertion site. The difference is how far they travel. A PICC is long enough — usually 40 to 60 cm — to thread all the way from the arm through the subclavian vein and into the superior vena cava, ending just above or at the junction with the heart’s right atrium. A midline, at 8 to 12 cm, stops in the arm.

Despite this difference in reach, midlines and PICCs can stay in place for similar durations. Average dwell times for midlines range from roughly 8 to 16 days, which far exceeds short peripheral IVs (typically 3 to 4 days) and overlaps with the range reported for PICCs.³ The two main reasons hospitals choose a midline over a PICC are difficult venous access (when short peripheral IVs keep failing) and short-term IV antibiotic therapy expected to last no more than about 30 days.⁴ When the treatment plan calls for medications that require central venous access — like certain chemotherapy drugs, highly concentrated nutrition formulas, or very acidic or alkaline solutions — a midline cannot substitute for a PICC.

What the Tip Location Means for Medications

Because a midline tip sits in a peripheral vein rather than a large central vessel, the menu of infusates it can safely deliver is more limited. The general rule is that solutions infused through a midline should have a pH between 5 and 9 and an osmolarity below about 500 mOsm.⁵ Solutions outside those ranges can damage the smaller vein walls, causing irritation, inflammation, or outright tissue injury.

In practice, this means midlines handle most standard IV antibiotics, normal saline, and many common medications comfortably. They are not appropriate for vasopressors, parenteral nutrition with high dextrose concentrations, or drugs like vancomycin at certain concentrations that push past those pH or osmolarity limits. If a clinician realizes partway through a hospital stay that a patient needs something outside the midline’s safe range, the device typically has to be replaced with a PICC or another central line.

Thrombosis Risk and What Drives It

Blood clots are the complication that generates the most debate around midlines. A large meta-analysis pooling data from over 40,000 patients found that the prevalence of venous thromboembolism with midlines was roughly 4%, compared to about 2.3% with PICCs.⁶ That finding surprises many clinicians, because midlines are shorter and sit in smaller veins — intuitively, they seem less invasive. But the smaller vein diameter is part of the problem. A catheter occupying a larger fraction of a vein’s cross-section disrupts flow more, and slower-moving blood is more prone to clotting.

A prospective study tracking over 400 midline patients found symptomatic upper-arm thrombosis in about 4.5% of cases, translating to roughly 3.3 events per 1,000 catheter-days. Male sex and placement in the cephalic vein were both associated with higher risk.⁷ The cephalic vein finding is consistent with the tip-position research discussed earlier: that vein tends to be smaller and more superficial, so a catheter within it encounters slower flow and more wall contact.

Catheter diameter also plays a measurable role. An observational study comparing three sizes found that the largest midlines (5 French) had a thrombosis rate of about 12%, roughly triple the rate seen with 3 or 4 French catheters. Each additional day the catheter remained in place increased the odds of clotting by about 3%.⁸ The practical takeaway is that using the smallest catheter that meets the clinical need and removing it as soon as it’s no longer necessary both help reduce clot risk.

Infection Rates Compared to Central Lines

If midlines carry a higher clot risk than PICCs, they appear to offer an advantage in terms of bloodstream infections. A systematic review and meta-analysis found that midline use was associated with fewer catheter-related bloodstream infections on a per-patient basis compared to PICCs.⁹ The likely explanation is that a catheter tip sitting in a peripheral arm vein simply isn’t in contact with the large central vessels near the heart, where an infection can become life-threatening more quickly. Catheter-related bloodstream infections in central lines are a major patient safety concern in hospitals, so this relative advantage is a genuine reason clinicians opt for midlines when the medication requirements permit.

That said, infection rates for midlines are not zero. One single-center study tracking hospitalized patients recorded catheter-related infection in about 0.3% of midline placements, while occlusion was far more common at 17% and bleeding at the insertion site occurred in 12%.¹⁰ The infection rate is low, but mechanical nuisances like clogging and oozing at the site are routine realities of living with a midline.

Other Mechanical Complications

Beyond thrombosis and infection, the most frequent problems with midlines are the everyday mechanical ones. A systematic review aggregating data from thousands of midline and long peripheral catheters found that midlines had lower rates of exit-site infection, leaking, infiltration, and accidental dislodgment compared to shorter long peripheral catheters. The rate of complete occlusion and malfunction for midlines was about 1.3 per 1,000 catheter-days.¹¹

Occlusion deserves special mention because it is the single most common complication reported in some datasets. A catheter tip sitting in a relatively small vein can get pressed against the vessel wall when the patient bends their arm, momentarily blocking flow. Over time, fibrin sheaths can build up around the tip, gradually restricting flow even when the arm is straight. Nurses typically manage this with flushing protocols, but persistent occlusion sometimes forces the catheter’s removal.

Accidental removal or dislodgment is another practical concern, particularly for patients who are confused, restless, or moving frequently. Because the catheter exits the skin on the upper arm, it sits in a spot that’s vulnerable during dressing changes, bathing, and transfers in and out of bed. Securing the catheter well and educating the patient (or their caregivers) about protecting the site can reduce unplanned removals.

Blood Draws Through a Midline

One practical advantage of a midline that patients often appreciate is the ability to draw blood through it, sparing them additional needle sticks. A study comparing blood samples collected from midline catheters with those obtained by standard venipuncture found the two methods clinically equivalent across all tested analytes, with results falling within medically acceptable error margins.¹² This is a meaningful quality-of-life benefit for hospitalized patients who face daily lab draws, especially those with limited or difficult peripheral veins. Not every hospital policy permits blood sampling through midlines, but the evidence supports it as reliable when done correctly.

Cost Considerations

Midlines occupy an interesting middle ground in hospital economics. They cost more to insert than a standard short peripheral IV — they require ultrasound, a trained inserter, and a more expensive catheter kit. But they last much longer, which means fewer restarts, fewer supplies consumed over a hospital stay, and less nursing time devoted to troubleshooting failed IVs. A cost-comparison study found that midlines saved money compared to both short peripheral catheters and PICCs across treatment durations of one to three weeks, with savings ranging from roughly €39 over a 7-day period against short peripherals to about €102 over 14 days against PICCs.¹³

The cost advantage shrinks or disappears if the midline develops an early complication that forces removal, or if the patient’s therapy changes to require a medication that demands central access. In those cases, the patient ends up with both the cost of the midline and the cost of the replacement device. This is why accurate treatment-duration planning up front matters: a midline makes the most financial sense when clinicians are reasonably confident the therapy will stay within the device’s capabilities for the expected course.

What Living with a Midline Feels Like

Patient-experience data on midlines is thinner than the complication literature, partly because many studies lump midlines together with other peripheral catheters. A large cross-sectional survey in Norway assessed patient perceptions of peripherally inserted venous catheters across multiple hospitals, measuring comfort, mobility, and daily-life impact on five-point scales. Scores for discomfort during insertion, ongoing catheter comfort, tenderness, and itching all landed in a moderate range, suggesting that most patients tolerate the catheter but don’t find it entirely unobtrusive.¹⁴

Patients commonly report that getting dressed over the catheter arm, moving the arm freely, and showering are the most frustrating aspects. The upper-arm location actually helps with some of these issues compared to catheters in the hand or forearm — you can type, eat, and write without the device catching on surfaces. But the dressing still needs to stay dry, the tubing needs to be managed during sleep, and some patients feel self-conscious about the visible bandaging. For people who have been through repeated IV failures in their hands and forearms, though, the trade-off is usually welcome.

When a Midline Is Not the Right Choice

Knowing where the tip ends helps clarify when a midline is inappropriate. Any therapy requiring central venous access by its nature — total parenteral nutrition, continuous vasopressor infusions, highly caustic chemotherapy agents, or solutions with extreme pH or osmolarity — rules out a midline because those substances need the rapid dilution that only the high-flow central veins near the heart can provide. Patients who are expected to need IV access for many weeks or months are also generally better served by a PICC or tunneled central line, since the peripheral veins hosting a midline are more prone to wear and complications over extended periods.

There are also patient-specific factors that influence the decision. People with advanced chronic kidney disease, for example, present a special consideration because the arm veins may be needed for future dialysis access. The decision to place a midline in that population involves weighing the immediate need for IV access against the long-term preservation of venous real estate in the arm. Similarly, patients with known clotting disorders or a history of upper-extremity deep vein thrombosis may be steered toward alternative devices where the risk-benefit calculation tilts differently.

The anatomy itself can also be a limiting factor. If ultrasound assessment shows that the target veins are too small, too deep, or too tortuous to safely accommodate the catheter, clinicians will either try a different insertion site or move to a different device altogether. Unlike a PICC, which has more room to navigate through the longer venous course, a midline’s short length means the insertion vein has to be large enough and straight enough to accept the catheter without kinking.